Abstract:Pluripotent stem cells (PSCs) offer an exciting resource for probing human biology; however, gene-editing efficiency remains relatively low in many cell types, including stem cells. Gene-editing using the CRISPR-Cas9 system offers an attractive solution that improves upon previous gene-editing approaches; however, like other technologies, off-target mutagenesis remains a concern. High-fidelity Cas9 variants greatly reduce off-target mutagenesis and offer a solution to this problem. To evaluate their utility as part of a cell-based gene-editing platform, human PSC lines were generated with a high-fidelity (HF) tetracycline-inducible engineered Streptococcus pyogenes SpCas9 (HF-iCas9) integrated into the AAVS1 safe harbor locus. By engineering cells with controllable expression of Cas9, we eliminated the need to include a large Cas9-expressing plasmid during cell transfection. Delivery of genetic cargo was further optimized by packaging DNA targeting guide RNAs (gRNAs) and donor fragments into a single plasmid backbone. The potential of homology-directed repair (HDR) based gene knock-in at the CLYBL safe harbor site and endogenous SOX2 and SIX6 genes were demonstrated. Moreover, we used non-homologous end-joining (NHEJ) for gene knockout of disease-relevant alleles. These high-fidelity CRISPR tools and the resulting HF-iCas9 cell lines will facilitate the production of cell-type reporters and mutants across different genetic backgrounds.

Generation of a TSC2 knockout embryonic stem cell line by CRISPR/Cas9 editing

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Generation of a TRPV1 Knockout Human Pluripotent Stem Cell Line (Wae009-a-u) Using CRISPR/Cas9.

Generation of a ISL1 homozygous knockout stem cell line (WAe009-A-1G) by episomal vector-based CRISPR/Cas9 system

Engineering Human Stem Cell Lines with Inducible Gene Knockout Using CRISPR/Cas9

Generation of a heterozygous Calsequestrin 2 F189L iPSC line (UMGi158-B) by CRISPR/Cas9 genome editing to investigate the cardiac pathophysiology of Takotsubo Syndrome and Catecholaminergic Polymorphic Ventricular Tachycardia

Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9

Generation of a tdTomato-GAD67 reporter human epilepsia mutation induced pluripotent stem cell line, USTCi001-A-2, using CRISPR/Cas9 editing

A Tet-Inducible CRISPR Platform for High-Fidelity Editing of Human Pluripotent Stem Cells

Generation of a homozygous DNAJC19 knockout human embryonic stem cell line by CRISPR/Cas9 system

Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies.

Generation of a Bag1 Homozygous Knockout Mouse Embryonic Stem Cell Line Using CRISPR/Cas9.

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9

Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system

Generation of induced pluripotent stem cell line (TMOi001-A-11) carrying a homozygous deletion in the synemin gene using CRISPR/Cas9

An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

Generation of a homozygous (MCRIi031-A-3) WT1 knockout human iPSC line

Generation of ID1/3 knockout human embryonic stem cell lines (WAe009-A-2A and WAe009-A-2B) derived from H9 using CRISPR/Cas9

Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing

Generation of FOXJ1-EGFP knock-in reporter human embryonic stem cell line, WAe001-A-2D, using CRISPR/Cas9-based gene targeting

CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein